ChronosDx

HealthcareSeedLondon, UK

Latest round

Seed

Last raised

Aug 2022

Total raised

Undisclosed

Investors

1

About ChronosDx

Based in London, UK, ChronosDx Ltd. develops bioassay technology that is used in the process of drug development. The company offers bioassay technology which is useful in drug development as well as enables in vitro diagnostics in healthcare. Additionally, its platform detects biomarkers such as cell-free DNA, micro RNA, proteins, metabolites, and exosomes. Furthermore, it enables in-line and in vivo monitoring of biomarkers. The firm’s technology facilitates the testing of new drugs, validation of disease biomarkers, and translates biomarker signatures into high-performance tests across the academic group, drug and diagnostic development companies, and CROs.

Who invested in ChronosDx

1 investor across 1 round

See all investors in ChronosDx

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Aug 5, 2022

    Amount

    Undisclosed

    Investors

    Locked

Questions about ChronosDx

Who invested in ChronosDx?

ChronosDx has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ChronosDx raised?

ChronosDx has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did ChronosDx last raise money?

ChronosDx's most recent round on record is a Seed, in Aug 2022.

What does ChronosDx do?

Based in London, UK, ChronosDx Ltd.

Where is ChronosDx headquartered?

ChronosDx is headquartered in London, UK.

Which VCs invest in companies like ChronosDx?

Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at ChronosDx's stage. Their profiles are linked below.

Raising like ChronosDx? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.